Characterizing Major Bleeding in Patients With Nonvalvular Atrial Fibrillation: A Pharmacovigilance Study of 27 467 Patients Taking Rivaroxaban-Reference-Cited by-同舟云学术

Characterizing Major Bleeding in Patients With Nonvalvular Atrial Fibrillation: A Pharmacovigilance Study of 27 467 Patients Taking Rivaroxaban

Published:2015-01-14 Issue:2 Volume:38 Page:63-68
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clin Cardiol

Author:

Tamayo Sally¹,Frank Peacock W.²,Patel Manesh³,Sicignano Nicholas⁴,Hopf Kathleen P.⁴,Fields Larry E.⁵,Sarich Troy⁶,Wu Shujian⁷,Yannicelli Daniel⁵,Yuan Zhong⁸

Affiliation:

1. Department of Cardiology, Naval Medical Center Portsmouth, Virginia

2. Department of Emergency Medicine, Baylor College of Medicine Houston, Texas

3. Department of Cardiology Duke University Health System and Duke Clinical Research Institute Durham, North Carolina

4. Department of Clinical Epidemiology, Health ResearchTx Trevose, Pennsylvania

5. Department of US Medical Affairs, Janssen Scientific Affairs, LLC Raritan, New Jersey

6. Department of Real World Evidence, Janssen Scientific Affairs, LLC Titusville, New Jersey

7. Department of Global Medical Organization, Janssen Research and Development, LLC Raritan, New Jersey

8. Department of Epidemiology, Janssen Research and Development, LLC Titusville, New Jersey

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/clc.22373

Reference14 articles.

1. The Clinical Profile and Pathophysiology of Atrial Fibrillation

2. Stroke Prevention in Atrial Fibrillation

3. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

4. Apixaban versus Warfarin in Patients with Atrial Fibrillation

5. Dabigatran versus Warfarin in Patients with Atrial Fibrillation

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering and evaluation of FXa bypassing agents that restore hemostasis following Apixaban associated bleeding;Nature Communications;2024-05-09

2. Nomogram for predicting bleeding events in nonvalvular atrial fibrillation patients receiving rivaroxaban: A retrospective study;Health Science Reports;2024-01

3. Identification of International Society on Thrombosis and Haemostasis major and clinically relevant non-major bleed events from electronic health records: a novel algorithm to enhance data utilisation from real-world sources;International Journal of Population Data Science;2023-10-02

4. Lower mortality with andexanet alfa vs 4-factor prothrombin complex concentrate for factor Xa inhibitor-related major bleeding in a U.S. hospital-based observational study;Research and Practice in Thrombosis and Haemostasis;2023-08

5. Patrones y resultados del cambio de anticoagulantes orales directos en la fibrilación auricular no valvular: experiencia en la práctica clínica en España;Revista Clínica Española;2023-06